Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 705475
                    [Title] => MSD's cholesterol-lowering drug cuts  atherosclerotic events in CKD patients
                    [Summary] => 
Global health care company MSD (known as Merck in the US and Canada) has good news for patients with chronic kidney disease (CKD).
                    [DatePublished] => 2011-07-14 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

PROFESSOR COLIN BAIGENT

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 705475
                    [Title] => MSD's cholesterol-lowering drug cuts  atherosclerotic events in CKD patients
                    [Summary] => 
Global health care company MSD (known as Merck in the US and Canada) has good news for patients with chronic kidney disease (CKD).
                    [DatePublished] => 2011-07-14 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

MSD's cholesterol-lowering drug cuts atherosclerotic events in CKD patients

July 14, 2011 - 12:00am

Global health care company MSD (known as Merck in the US and Canada) has good news for patients with chronic kidney disease (CKD).

Science and Environment